vs

Side-by-side financial comparison of BADGER METER INC (BMI) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.

BADGER METER INC is the larger business by last-quarter revenue ($234.1M vs $150.6M, roughly 1.6× GLAUKOS Corp). BADGER METER INC runs the higher net margin — 14.3% vs 6.2%, a 8.1% gap on every dollar of revenue. On growth, GLAUKOS Corp posted the faster year-over-year revenue change (41.2% vs 14.1%). Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs 9.2%).

Badger Meter Inc. is a leading global provider of flow measurement and control solutions, serving water utilities, industrial, commercial, and residential customer segments. Its core offerings include smart water meters, IoT-enabled usage monitoring systems, and supporting software that help clients track resource consumption, cut waste, and boost operational efficiency, with key markets spanning North America, Europe, and the Asia-Pacific region.

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

BMI vs GKOS — Head-to-Head

Bigger by revenue
BMI
BMI
1.6× larger
BMI
$234.1M
$150.6M
GKOS
Growing faster (revenue YoY)
GKOS
GKOS
+27.0% gap
GKOS
41.2%
14.1%
BMI
Higher net margin
BMI
BMI
8.1% more per $
BMI
14.3%
6.2%
GKOS
Faster 2-yr revenue CAGR
GKOS
GKOS
Annualised
GKOS
25.4%
9.2%
BMI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BMI
BMI
GKOS
GKOS
Revenue
$234.1M
$150.6M
Net Profit
$33.6M
$9.4M
Gross Margin
39.7%
77.9%
Operating Margin
18.4%
9.0%
Net Margin
14.3%
6.2%
Revenue YoY
14.1%
41.2%
Net Profit YoY
9.3%
EPS (diluted)
$1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BMI
BMI
GKOS
GKOS
Q1 26
$150.6M
Q4 25
$234.1M
$143.1M
Q3 25
$222.2M
$133.5M
Q2 25
$238.1M
$124.1M
Q1 25
$222.2M
$106.7M
Q4 24
$205.2M
$105.5M
Q3 24
$208.4M
$96.7M
Q2 24
$216.7M
$95.7M
Net Profit
BMI
BMI
GKOS
GKOS
Q1 26
$9.4M
Q4 25
$33.6M
$-133.7M
Q3 25
$35.1M
$-16.2M
Q2 25
$34.6M
$-19.7M
Q1 25
$38.4M
$-18.1M
Q4 24
$30.7M
$-33.6M
Q3 24
$32.0M
$-21.4M
Q2 24
$33.1M
$-50.5M
Gross Margin
BMI
BMI
GKOS
GKOS
Q1 26
77.9%
Q4 25
39.7%
-1.1%
Q3 25
43.1%
78.4%
Q2 25
41.1%
78.3%
Q1 25
42.9%
77.2%
Q4 24
40.3%
72.9%
Q3 24
40.2%
76.6%
Q2 24
39.4%
76.4%
Operating Margin
BMI
BMI
GKOS
GKOS
Q1 26
9.0%
Q4 25
18.4%
-97.7%
Q3 25
20.7%
-12.3%
Q2 25
18.8%
-18.3%
Q1 25
22.2%
-19.4%
Q4 24
19.1%
-27.2%
Q3 24
19.5%
-25.5%
Q2 24
19.2%
-31.3%
Net Margin
BMI
BMI
GKOS
GKOS
Q1 26
6.2%
Q4 25
14.3%
-93.4%
Q3 25
15.8%
-12.2%
Q2 25
14.5%
-15.8%
Q1 25
17.3%
-17.0%
Q4 24
15.0%
-31.8%
Q3 24
15.4%
-22.1%
Q2 24
15.3%
-52.8%
EPS (diluted)
BMI
BMI
GKOS
GKOS
Q1 26
Q4 25
$1.13
$-2.34
Q3 25
$1.19
$-0.28
Q2 25
$1.17
$-0.34
Q1 25
$1.30
$-0.32
Q4 24
$1.04
$-0.56
Q3 24
$1.08
$-0.39
Q2 24
$1.12
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BMI
BMI
GKOS
GKOS
Cash + ST InvestmentsLiquidity on hand
$276.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$713.3M
$670.9M
Total Assets
$973.6M
$893.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BMI
BMI
GKOS
GKOS
Q1 26
$276.7M
Q4 25
$90.8M
Q3 25
$98.2M
Q2 25
$100.8M
Q1 25
$114.3M
Q4 24
$169.6M
Q3 24
$100.1M
Q2 24
$68.1M
Stockholders' Equity
BMI
BMI
GKOS
GKOS
Q1 26
$670.9M
Q4 25
$713.3M
$656.2M
Q3 25
$702.5M
$769.5M
Q2 25
$677.6M
$765.1M
Q1 25
$641.7M
$764.0M
Q4 24
$606.2M
$766.9M
Q3 24
$591.2M
$668.5M
Q2 24
$563.1M
$665.2M
Total Assets
BMI
BMI
GKOS
GKOS
Q1 26
$893.3M
Q4 25
$973.6M
$893.5M
Q3 25
$978.3M
$999.4M
Q2 25
$936.4M
$987.0M
Q1 25
$899.6M
$966.2M
Q4 24
$816.4M
$974.8M
Q3 24
$802.9M
$926.5M
Q2 24
$781.3M
$919.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BMI
BMI
GKOS
GKOS
Operating Cash FlowLast quarter
$54.8M
Free Cash FlowOCF − Capex
$50.8M
FCF MarginFCF / Revenue
21.7%
Capex IntensityCapex / Revenue
1.7%
Cash ConversionOCF / Net Profit
1.63×
TTM Free Cash FlowTrailing 4 quarters
$169.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BMI
BMI
GKOS
GKOS
Q1 26
Q4 25
$54.8M
$6.8M
Q3 25
$51.3M
$-10.1M
Q2 25
$44.6M
$7.0M
Q1 25
$33.0M
$-18.5M
Q4 24
$52.1M
$507.0K
Q3 24
$45.1M
$-9.6M
Q2 24
$36.4M
$-18.4M
Free Cash Flow
BMI
BMI
GKOS
GKOS
Q1 26
Q4 25
$50.8M
$3.9M
Q3 25
$48.2M
$-11.7M
Q2 25
$40.6M
$5.8M
Q1 25
$30.1M
$-20.5M
Q4 24
$47.4M
$-1.2M
Q3 24
$42.0M
$-11.0M
Q2 24
$34.1M
$-20.5M
FCF Margin
BMI
BMI
GKOS
GKOS
Q1 26
Q4 25
21.7%
2.7%
Q3 25
21.7%
-8.8%
Q2 25
17.1%
4.7%
Q1 25
13.5%
-19.2%
Q4 24
23.1%
-1.2%
Q3 24
20.1%
-11.4%
Q2 24
15.7%
-21.4%
Capex Intensity
BMI
BMI
GKOS
GKOS
Q1 26
Q4 25
1.7%
2.0%
Q3 25
1.4%
1.2%
Q2 25
1.7%
0.9%
Q1 25
1.3%
1.8%
Q4 24
2.3%
1.6%
Q3 24
1.5%
1.5%
Q2 24
1.1%
2.2%
Cash Conversion
BMI
BMI
GKOS
GKOS
Q1 26
Q4 25
1.63×
Q3 25
1.46×
Q2 25
1.29×
Q1 25
0.86×
Q4 24
1.70×
Q3 24
1.41×
Q2 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BMI
BMI

Transferred At Point In Time$198.6M85%
Transferred Over Time$22.1M9%
Other$13.4M6%

GKOS
GKOS

Segment breakdown not available.

Related Comparisons